Laird Norton Wetherby Trust Company’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.48M Buy
48,853
+1
+0% +$87 0.09% 178
2026
Q1
$4.16M Sell
48,852
-1,446
-3% -$129K 0.09% 175
2025
Q4
$3.97M Buy
+50,298
New +$3.94M 0.08% 185
2023
Q4
– Sell
-2,868
Closed -$204K – 103
2023
Q3
$204K Hold
2,868
– – 0.03% 108
2023
Q2
$221K Hold
2,868
– – 0.03% 105
2023
Q1
$216K Hold
2,868
– – 0.03% 109
2022
Q4
$226K Buy
+2,868
New +$215K 0.03% 101
2022
Q3
– Sell
-2,947
Closed -$236K – 81
2022
Q2
$236K Sell
2,947
-2,300
-44% -$180K 0.03% 102
2022
Q1
$397K Sell
5,247
-218
-4% -$17.3K 0.04% 120
2021
Q4
$466K Hold
5,465
– – 0.04% 116
2021
Q3
$413K Buy
5,465
+270
+5% +$21.4K 0.04% 113
2021
Q2
$422K Sell
5,195
-245
-5% -$20K 0.04% 101
2021
Q1
$465K Hold
5,440
– – 0.05% 95
2020
Q4
$465K Buy
+5,440
New +$450K 0.05% 94

Other funds holding CL

Laird Norton Wetherby Trust Company's CL Position: Q2 2026 in Review

Laird Norton Wetherby Trust Company increased its Colgate-Palmolive (CL) stake by 0% in Q2 2026, buying an estimated $87 and bringing the position to 48,853 shares worth $4.48M. The position accounts for 0.09% of the portfolio, ranked #178.

Laird Norton Wetherby Trust Company first reported a position in CL in Q4 2020 and has held it in 14 quarters since. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Laird Norton Wetherby Trust Company held 48,853 shares of Colgate-Palmolive worth $4.48M as of Q2 2026.
  • Laird Norton Wetherby Trust Company bought 1 Colgate-Palmolive share in Q2 2026, an estimated $87.
  • Colgate-Palmolive made up 0.09% of Laird Norton Wetherby Trust Company's portfolio in Q2 2026, its #178 holding.
  • Laird Norton Wetherby Trust Company first reported a position in Colgate-Palmolive in Q4 2020 and has held it in 14 quarters since.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.